0
0

Rx Flexibility for States Act

1/16/2023, 1:47 AM

Congressional Summary of S 2536

Rx Flexibility for States Act - Amends title XIX (Medicaid) of the Social Security Act to declare that nothing prohibits a State: (1) from directly entering into drug rebate agreements that are similar to a specified rebate agreement with a manufacturer to ensure the affordability of outpatient prescription drugs in order to provide access to them by residents of a State who are not otherwise eligible for medical assistance under the Medicaid program; or (2) from making prior authorization a condition of not participating in such a similar rebate agreement.

Read the Full Bill

Current Status of Bill S 2536

Bill S 2536 is currently in the status of Bill Introduced since May 21, 2002. Bill S 2536 was introduced during Congress 107 and was introduced to the Senate on May 21, 2002.  Bill S 2536's most recent activity was Sponsor introductory remarks on measure. (CR S5465-5468) as of June 13, 2002

Bipartisan Support of Bill S 2536

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
10
Democrat Cosponsors
9
Republican Cosponsors
0
Unaffiliated Cosponsors
1

Policy Area and Potential Impact of Bill S 2536

Primary Policy Focus

Health

Potential Impact Areas

- Ambulatory care
- Commerce
- Consumer discounts
- Drug industry
- Drugs
- Medicaid
- Prescription pricing
- Rebates
- Social Welfare

Alternate Title(s) of Bill S 2536

Rx Flexibility for States Act
A bill to amend title XIX of the Social Security Act to clarify that section 1927 of that Act does not prohibit a State from entering into drug rebate agreements in order to make outpatient prescription drugs accessible and affordable for residents of the State who are not otherwise eligible for medical assistance under the medicaid program.
Rx Flexibility for States Act

Comments